Cetero Research

 

Today's Research for Tomorrow's Healthcare
 
 
+
+
+
 +
+
 
   
     
 
Newly Validated Assays
Available assay list  
Method development and validation  
LC/MS/MS  
Immunochemistry  


  Compound Matrix Sensitivity Methodology
       
Baclofen (R & S) Rat Plasma 0.01/0.01 ng/mL – 10.0/10.0 µg/mL LC/MS/MS
Baclofen (R & S) Plasma 1.00/1.00 to 700/700 ng/mL LC/MS/MS
Bisoprolol Plasma 0.200 – 150 ng/mL LC/MS/MS
Cetirizine Plasma 5.00 – 1000 ng/mL LC/MS/MS
D-Methylphenidate Plasma 0.100 – 20.0 ng/mL LC/MS/MS
Dutasteride Plasma 0.05 - 10.0 ng/mL LC/MS/MS
Estradiol Valerate Plasma 5.00 – 300.0 pg/mL LC/MS/MS
L-Methylphenidate Plasma 20.0-4000 pg/mL LC/MS/MS
Mesalamine Plasma 2.00 – 1375 ng/mL LC/MS/MS
Methimazole Plasma 5.0 – 500.0 ng/mL LC/MS/MS
Paricalcitol (High Range) Plasma 10.0 – 500.0 pg/mL LC/MS/MS
Sildenafil/N-Desmethylsildenafil Plasma 1.0 / 0.25 – 300.0/75.0 ng/mL LC/MS/MS
Trazodone (Low Range) Plasma 10.0 – 3000 ng/mL LC/MS/MS

 
 
 
|
|
|
|
|
|
 
Copyright © 2009 CRS Management. All rights reserved.
 
Developed by Web Interactive Technologies Baltimore Web Design